The His & Hers cast consists of Tessa Thompson, Jon Bernthal, Pablo Schreiber, Crystal Fox, Sunita Mani, Rebecca Rittenhouse, ...
Maple Tree Capital, an investment management company, released its Q3 2025 investor letter. A copy of the letter can be ...
Zacks Investment Research on MSN
Hims & Hers Health, Inc. (HIMS) dips more than broader market: What you should know
In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $33.05, marking a -3.09% move from the previous day. This change lagged the S&P 500's 0.14% loss on the day. Elsewhere, the Dow ...
Hims & Hers Health announced on Tuesday it will bundle Wegovy with the telehealth platform’s membership through a new collaboration with drugmaker Novo Nordisk. The bundle will offer Novo Nordisk’s ...
The trajectory of well-known health and wellness platform Hims & Hers is one that most entrepreneurs and investors would hope for. Not even six years old, the company has for the most part experienced ...
3don MSN
‘His & Hers’: Tessa Thompson & Jon Bernthal Detail Why Reuniting Brings Their Characters Pain
Netflix’s new thriller His & Hers, premiering January 8, 2026, follows estranged spouses Anna Andrews and Jack Harper as they reunite over a murder investigation. Tessa Thompson and Jon Bernthal talk ...
Asianet Newsable on MSN
Hims & Hers hit a GLP-1 speed bump this year — but growth is just cooling, not cracking
Hims & Hers has drawn scrutiny for selling compounded GLP-1 treatments – lower-cost, unapproved alternatives to blockbuster ...
Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make its weight loss drug Wegovy available on the telehealth company's platform ...
Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its telehealth ...
The market is just starting to notice the great things this small-cap stock has been doing for a while now. It often feels like you've missed the boat when you sit there reading about another stock ...
Hims & Hers Q2 revenue climbs 69% as company invests in more specialty care, international expansion
The COVID-19 pandemic spurred new players into the virtual care space, along with booming investments, but the increased competition is not slowing down Hims & Hers' growth. The consumer telehealth ...
The telehealth company is being criticized for its Super Bowl weight loss commercial. (Hims & Hers via YouTube) During the Super Bowl, Hims & Hers Health aired a commercial called “Sick of the System.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results